(continued)
- Trifluridine/Tipiracil (Lonsurf)
- Columvi (glofitamab-gxbm)
- Levoleucovorin (Fusilev, Khapzory)
- Leucovorin (Wellcovorin)
- Vonjo (pacritinib)
- Jakafi (Ruxolitinib)
- Inrebic (fedratinib)
- Jaypirca (Pirtobrutinib)
- Libtayo (cemiplimab-rwlc)
- Venclexta (venetoclax)
- Gavreto (pralsetinib)
- Jemperli (Dostarlimab-Gxly)
- Rubraca (rucaparib)
- Talzenna (talazoparib)
- Tecvayli (teclistamab-cqyv)
- Blincyto (blinatumomab)
- Vyloy (zolbetuximab-clzb)
- Lutetium Lu 177 Dotatate (Lutathera, Bexlutry, Bravnetsa)
- Brukinsa (zanubrutinib)
- Itovebi (inavolisib)
- Tecentriq (Atezolizumab)
- Nubeqa (darolutamide)
- Erleada (apalutamide)
- Bortezomib (Velcade, Boruzu)
- Kyprolis (carfilzomib)
- Ninlaro (ixazomib)
- Tecentriq Hybreza (Atezolizumab/Hyaluronidase-Tqjs)
- Alecensa (alectinib)
- Kisqali (ribociclib)
- Kisqali Femara Co-Pack (ribociclib and letrozole)